{"changes":[{"companyHref":"/c/amphixbio-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/2101704/000210170425000001/primary_doc.xml","domain":"amphixbio.com","fact":"latest round","name":"Amphix Bio, Inc.","new":{"amountUsd":10300000,"date":"2025-12-19","lead":null,"type":null},"old":{"amountUsd":10300000,"date":"2025-12-19","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"amphixbio-com","status":"sourced","url":"https://whoraisedwhat.com/c/amphixbio-com"},{"companyHref":"/c/amphixbio-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/2101704/000210170425000001/primary_doc.xml","domain":"amphixbio.com","fact":"provenance:round","name":"Amphix Bio, Inc.","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2101704/000210170425000001/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"amphixbio-com","status":"sourced","url":"https://whoraisedwhat.com/c/amphixbio-com"}],"country":"US","description":"Amphix Bio develops supramolecular peptide therapeutics that form synthetic nanostructure scaffolds to drive regeneration after CNS injury, neuro-inflammatory disease and musculoskeletal damage. It serves patients with acute spinal cord injury, degenerative disc disease and similar high-need indications. Northwestern-derived cell-free peptide chemistry ships as defined synthetic drugs, sidestepping cell-therapy manufacturing complexity.","domain":"amphixbio.com","employees":null,"founded":2021,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":41.875562,"lng":-87.624421,"location":"CHICAGO, IL","name":"Amphix Bio, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":10300000,"currency":"USD","date":"2025-12-19","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2101704/000210170425000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/2101704/000210170425000001/primary_doc.xml"}],"slug":"amphixbio-com","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2101704/000210170425000001/primary_doc.xml"},{"fact":"existence","publisher":"amphixbio.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://amphixbio.com"},{"fact":"description","publisher":"amphixbio.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://amphixbio.com"}],"stage":null,"techStack":["Google Cloud CDN","Sentry","Vercel Speed Insights","WebsiteBuilder","Wix","Google Cloud","React","lodash ."],"totalRaisedUsd":10300000,"updatedAt":"2026-05-05"}